This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Analysts' Actions: FDX YHOO AGN CLNE MRO


Arbor Realty Trust (ABR) upgraded to hold at TheStreet ratings.

Allergan (AGN - Get Report) rated new Hold at Canaccord. Valuation call, based on a $101 price target.

Baxter (BAX) rated new Outperform at BMO. $70 price target. Company has a solid pipeline and can deliver consistent, long-term growth.

A.M. Castle (CAS) upgraded to hold at TheStreet ratings.

Clean Energy (CLNE - Get Report) rated new Hold at Keybanc. Company lacks potential near-term catalysts.

CSX (CSX) downgraded at UBS to Neutral from Buy, UBS said. $24.50 price target. Catalyst lacking and Q3 estimates falling.

Dover (DOV) rated new Buy at Capstone. $71 price target. Company is focused on targeted growth areas.

FMC (FMC) rated new Neutral at Goldman. Valuation call, based on a $62 price target.

Corning (GLW) upgraded at Goldman from Neutral to Buy, Goldman Sachs said. $16 price target. LCD glass cycle appears to be bottoming and the company is cutting back on capital spending.

Hasbro (HAS) downgraded at Needham from Buy to Hold, Needham said. Valuation call.

Kansas City Southern (KSU) downgraded at UBS to Sell from Neutral, UBS said. $74 price target. Lack of catalyst and trades at premium to peers.

Lam Research (LRCX) downgraded at Citigroup to Neutral from Buy, Citigroup said. $34 price target. Apple's shift to TSMC from Samsung could be negative.

Marathon Oil (MRO - Get Report) upgraded at Credit Suisse from Neutral to Outperform, Credit Suisse said. $37 price target. Estimates also boosted, as the Paloma acquisition should add to earnings.

Norfolk Southern (NSC) downgraded at UBS to Neutral from Buy, UBS said. $79 price target. Valuation trap lacking compelling investment case.

Northern Trust (NTRS) downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. Valuation call, based $40 price target.

Charles Schwab (SCHW) downgraded at Goldman from Buy to Neutral, Goldman Sachs said. Company is leveraged to lower RMBS yields. $14 price target.

St. Jude (STJ) upgraded at Wells from Market Perform to Outperform, Wells Fargo said. ICD market is stabilizing and the company should benefit from a weaker dollar.

Union Pacific (UNP) downgraded at UBS to Neutral from Buy, UBS said. $135 price target. Premium valuation moves us to sidelines.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
AGN $240.22 1.21%
CLNE $5.27 0.00%
FDX $164.59 0.00%
MRO $25.90 0.00%
YHOO $45.10 0.00%


DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs